CytomX Therapeutics (CTMX) Net Equity Issued and Repurchased (2014 - 2026)
CytomX Therapeutics (CTMX) reported Net Equity Issued and Repurchased of $56,000 for Q2 2026, down 99.9% from $93.37 million a year earlier and down 100.0% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CytomX Therapeutics' Net Equity Issued and Repurchased came in at $244.67 million, up 156.4% year-over-year; for FY2025, it came in at $109.64 million.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 57.6% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $6.91 million in FY2024 (-76.7%), $29.67 million in FY2023, $648,000 in FY2022 (-99.4%) and $107.71 million in FY2021 (+854.2%).
- The Q2 2026 figure ranks as the lowest quarterly Net Equity Issued and Repurchased since Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | CytomX Therapeutics | 592.69 Mn | -364.98 Mn | - | 56,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56,000.00 |
| Mar 31, 2026 | 228.35 Mn |
| Dec 31, 2025 | 16.26 Mn |
| Jun 30, 2025 | 93.37 Mn |
| Dec 31, 2024 | 2.07 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Mar 31, 2024 | 174,000.00 |
| Sep 30, 2023 | 29.35 Mn |
| Jun 30, 2023 | 317,000.00 |
| Dec 31, 2022 | 190,000.00 |
| Jun 30, 2022 | 451,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Mar 31, 2021 | 107.71 Mn |
| Dec 31, 2020 | 7.42 Mn |
| Sep 30, 2020 | 167,000.00 |
| Jun 30, 2020 | 1.55 Mn |
| Mar 31, 2020 | 2.16 Mn |
| Dec 31, 2019 | 401,000.00 |
| Sep 30, 2019 | 63,000.00 |
| Jun 30, 2019 | 698,000.00 |
API Access
CytomX Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();